… you’re not alone. In this audio from our Third Thursdays Webinar replay, expert panelists share practical tips for … not yet taking PD medication. Connect with the PPMI team today at  michaeljfox.org/podcast-ppmi-sites . Anyone over … . Christina Destro Associate Director Research Communications …

… is now seeking a pharmaceutical partner to move this drug into later stages of clinical development. If all goes well, … regulatory approval by 2016 or 2017. Positive data from an early clinical trial funded by MJFF demonstrating that a … as a dyskinesia therapy. The next step for a team of researchers including Anders Björklund, MD, PhD, from Lund …

… This week, research published in Neurology , the medical journal of the … prevalent among smokers as compared to non-smokers, and early results from pre-clinical studies have shown potential … to begin this spring called NIC-PD that will begin to look into the disease modifying potential of a nicotine patch, as …

… is a trained biophysicist and biochemist who transitioned into system neuroscience during his postdoctoral work at the … brain stimulation in patients. Dr. Prigge started his own research group at the Leibniz Institute for Neuroscience in … in health and disease in mouse models. He investigates how early changes in the neuronal circuit of catecholaminergic …

… drug discovery. She specializes in translating R&D strategy into innovative programs and partnerships, and she is … level execution. She initiated and led projects in early stage drug discovery, bio-nanotechnology tool … for reliable transition of prototype technology from research to commercial use. She currently serves as a …

… a cure. The only way is to participate in clinical research,” said user Gary Rafaloff of Malboro, New Jersey. … more than 40,000 potential research volunteers and lists nearly 450 ongoing Parkinson’s studies in nine countries from … has increased the number of patients screened and enrolled into studies I work on,” said Grace Bwala, a research …